MEDAX | MEDBX | MEDAX / MEDBX | |
Total Expense Ratio | 1.06 | 1.81 | 59% |
Annual Report Gross Expense Ratio | 1.07 | 1.82 | 59% |
Fund Existence | 27 years | 23 years | - |
Gain YTD | 7.912 | 7.353 | 108% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.4B | 7.4B | 100% |
Annual Yield % from dividends | 5.42 | 4.69 | 115% |
Returns for 1 year | 7.53 | 6.80 | 111% |
Returns for 3 years | 31.20 | 28.33 | 110% |
Returns for 5 years | 9.48 | 5.50 | 172% |
Returns for 10 years | 45.03 | 34.57 | 130% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LADIX | 25.03 | 0.03 | +0.12% |
ClearBridge Tactical Dividend Income I | |||
TCIWX | 27.09 | N/A | N/A |
Nuveen International Eq Idx W | |||
WHGSX | 21.30 | -0.06 | -0.28% |
Westwood Quality SmallCap Fund Inst | |||
MFLDX | 25.92 | -0.16 | -0.61% |
Cromwell Long Short Institutional | |||
FRESX | 38.90 | -0.46 | -1.18% |
Fidelity Real Estate Investment Port |